Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The U1 small nuclear ribonucleoprotein (U1 snRNP) complex is a major component of the spliceosome, the molecular machine responsible for removing introns from pre-mRNA [1, 4]. It is composed of the U1 small nuclear RNA (snRNA), a core of seven Sm proteins, and three specific proteins: U1-70K, U1A, and U1C [2, 4]. The primary function of U1 snRNP is to recognize and bind the 5' splice site of introns through base-pairing with the U1 snRNA, thereby initiating spliceosome assembly [4, 12]. Additionally, it plays a vital role in "telescripting," a process that prevents premature polyadenylation and ensures the transcription of long genes [1, 13]. Mutations or functional defects in U1 snRNP are implicated in neurodegenerative diseases such as Spinal Muscular Atrophy (SMA) and Amyotrophic Lateral Sclerosis (ALS), as well as in various cancers [3, 6, 14]. Therapeutically, U1 snRNP is targeted by small molecule splicing modulators like Risdiplam and Branaplam, which enhance its binding to specific splice sites to correct genetic defects [8, 9]. It is also a well-known autoantigen in systemic autoimmune diseases, where anti-U1 RNP antibodies serve as diagnostic markers [2].
Splicing modulation by stabilizing the interaction between the U1 snRNP complex and the 5' splice site of pre-mRNA to promote exon inclusion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U1 small nuclear ribonucleoprotein complex (U1 snRNP).